{"id":"F2018L01164","name":"Statement of Principles concerning reactive arthritis (Reasonable Hypothesis) (No. 75 of 2018)","slug":"statement-of-principles-concerning-reactive-arthritis-reasonable-hypothesis-no-75-of-2018","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":439727,"registerId":"F2018L01164-fast-fetch-1775955639841","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning reactive arthritis (Reasonable Hypothesis) (No. 75 of 2018)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nREACTIVE ARTHRITIS (Reasonable Hypothesis)\n\n(No. 75 of 2018)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 24 August 2018\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n|
Professor Nicholas Saunders AO
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning reactive arthritis (Reasonable Hypothesis) (No. 75 of 2018).\n\n2 Commencement\n\n This instrument commences on 24 September 2018.\n\n3 Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning reactive arthritis No. 26 of 2010 (Federal Register of Legislation No. F2010L01042) made under subsection 196B(2) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about reactive arthritis and death from reactive arthritis.\n\nMeaning of reactive arthritis\n\n(2) For the purposes of this Statement of Principles, reactive arthritis:\n\n(a) means an immune-mediated arthritis of more than four weeks' duration; and\n\n(b) is usually associated with evidence of a preceding extra-articular infection; and\n\n(c) excludes:\n\n(i) acute rheumatic fever;\n\n(ii) arthritis associated with viruses which are known to cause arthritis as part of the usual spectrum of clinical manifestations (for example, Ross River virus infection, Barmah Forest virus, rubella virus, parvovirus B19);\n\n(iii) leptospirosis;\n\n(iv) Lyme disease;\n\n(v) post-streptococcal reactive arthritis; and\n\n(vi) septic arthritis.\n\nNote: Typical clinical manifestations include a predominantly lower limb, asymmetric oligoarthritis and may include extra-articular manifestations, such as urethritis, cervicitis, conjunctivitis, skin lesions, sacroiliitis, spondylitis and enthesitis.\n\n(3) While reactive arthritis attracts ICD‑10‑AM code M02, in applying this Statement of Principles the meaning of reactive arthritis is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from reactive arthritis\n\n(5) For the purposes of this Statement of Principles, reactive arthritis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's reactive arthritis.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that reactive arthritis and death from reactive arthritis can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting reactive arthritis or death from reactive arthritis with the circumstances of a person's relevant service:\n\n(1) having an infection as specified within the three months before the clinical onset of reactive arthritis;\n\nNote: infection as specified is defined in the Schedule 1 - Dictionary. \n\n(2) having infection with human immunodeficiency virus at the time of the clinical onset of reactive arthritis;\n\n(3) being vaccinated with hepatitis B vaccine within the 30 days before the clinical onset of reactive arthritis;\n\n(4) having intravesical BCG therapy for malignant neoplasm of the bladder or intradermal BCG therapy for a malignant neoplasm within the 30 days before the clinical onset of reactive arthritis;\n\nNote: BCG therapy is defined in the Schedule 1 - Dictionary.\n\n(5) having active mycobacterial disease within the 30 days before the clinical onset of reactive arthritis;\n\nNote: active mycobacterial disease is defined in the Schedule 1 - Dictionary.\n\n(6) having intestinal bypass surgery within the one year before the clinical onset of reactive arthritis;\n\n(7) inability to obtain appropriate clinical management for reactive arthritis.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factor set out in subsection 9(7) applies only to material contribution to, or aggravation of, reactive arthritis where the person's reactive arthritis was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n active mycobacterial disease means an illness in which tuberculosis bacteria or atypical mycobacteria are multiplying and inducing an inflammatory response.\n\n BCG therapy means treatment with the Bacille Calmette-Guerin vaccine.\n\n infection as specified means:\n\n(a) clinical or laboratory evidence of a bowel infection; or\n\n(b) clinical or laboratory evidence of a sexually acquired urogenital infection (including proctitis and excluding genital warts and herpes simplex); or\n\n(c) clinical or laboratory evidence of an infection with Staphylococcus aureus, Chlamydia pneumoniae, Chlamydia psittaci or Chlamydia trachomatis.\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n reactive arthritis—see subsection 7(2).\n\n relevant service means:\n\n(a) operational service under the VEA;\n\n(b) peacekeeping service under the VEA;\n\n(c) hazardous service under the VEA;\n\n(d) British nuclear test defence service under the VEA;\n\n(e) warlike service under the MRCA; or\n\n(f) non-warlike service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"This instrument maintains its original narrow scope as a specific medical determination for reactive arthritis under the Veterans' Entitlements Act framework. It replaces an earlier 2010 version (No. 26 of 2010) but does not expand beyond its intended purpose of establishing causation factors for this specific condition in the veterans' compensation context."},"complexity_factors":["Multiple defined terms in Schedule 1 (8 explicit definitions plus cross-references)","Nested exclusions in the definition of reactive arthritis (6 specific exclusions in section 7(2))","Conditional logic in section 9(7) with temporal restrictions and a specific limitation in section 10(2)","Cross-referencing mechanism in section 11 allowing incorporation of other Statements of Principles by reference","Dual legislative framework application (VEA and MRCA) requiring understanding of two different compensation schemes","Specific temporal windows (3 months, 30 days, 1 year) that must be precisely calculated","Medical terminology requiring clinical interpretation (ICD-10-AM codes, specific pathogens, surgical procedures)"],"plain_english_summary":"This rulebook explains how to decide if reactive arthritis in veterans or defence members can be linked to service for compensation under the VEA or MRCA. It defines the “reasonable hypothesis” test and the specific medical triggers (infections, certain vaccines/therapies, surgical or treatment-related factors, or untreated pre-existing disease) needed to establish a plausible service connection.\n\nIf none of those triggers is shown, a claim is unlikely to succeed."},"flash_summary":{"complexity_score":3,"scope_assessment":{"changed":false,"description":"The instrument repeals the earlier Statement (s4) and restates the definition of reactive arthritis, exclusions, and the specific factors that can raise a reasonable hypothesis of service connection. The text itself does not expand or narrow the class of covered conditions beyond replacing the prior Statement; it retains an ICD‑10‑AM reference and sets temporal and evidentiary limits for the qualifying factors (see s7, s9 and Schedule 1)."},"complexity_factors":["Clear, limited scope: single condition (reactive arthritis) with explicit exclusions (s7(2)(c)).","Finite list of qualifying factors with specific temporal windows (s9(1)–(6) — e.g. 3 months, 30 days, 1 year) requiring temporal causation analysis.","Medical evidence requirement: clinical or laboratory evidence for specified infections and definitions in Schedule 1 (definitions of 'infection as specified', 'active mycobacterial disease', 'BCG therapy').","Interaction with other Statements of Principles: cross-reference mechanism if a factor refers to another disease covered by a different Statement (s11).","Legal threshold: uses the 'reasonable hypothesis' standard under subsection 196B(2) VEA (sections 3 and 8), not a higher probability test — affects evidentiary burden.","Service-connection linkage requirement: factors must be related to relevant service categories (s10 and Schedule definitions of 'relevant service'), introducing factual inquiry into service records.","Potentially open-ended evidentiary issue: 'inability to obtain appropriate clinical management' (s9(7)) may require assessment of access to care and timing (administrative and evidentiary burden).","Repeal and replacement of prior Statement (s4) — administrative transition implications for claims assessed under earlier instrument."],"plain_english_summary":"This Statement of Principles sets out how reactive arthritis (and death from it) is defined for veterans’ entitlement claims and specifies the medical factors and time limits that are sufficient to raise a “reasonable hypothesis” linking the condition to relevant service. It applies to claims under section 120A of the VEA and section 338 of the MRCA and lists infections, HIV, recent hepatitis B vaccination, BCG or mycobacterial disease, intestinal bypass surgery, and lack of appropriate clinical care as qualifying factors that decision-makers must consider."}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-reactive-arthritis-reasonable-hypothesis-no-75-of-2018","history":"/api/acts/statement-of-principles-concerning-reactive-arthritis-reasonable-hypothesis-no-75-of-2018/history","analysis":"/api/acts/statement-of-principles-concerning-reactive-arthritis-reasonable-hypothesis-no-75-of-2018/analysis","conflicts":"/api/acts/statement-of-principles-concerning-reactive-arthritis-reasonable-hypothesis-no-75-of-2018/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-reactive-arthritis-reasonable-hypothesis-no-75-of-2018/important-cases","documents":"/api/acts/statement-of-principles-concerning-reactive-arthritis-reasonable-hypothesis-no-75-of-2018/documents"}}